glp 1 for ckd Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Glucagon-like Peptide-1 Receptor Agonists: New

Fierce Healthcare article, 9 May 2023: [12] Thomas CE, Mauer EA, Shukla AP, Rathi S, Aronne LJ

Clinicians need to be aware of the growing grey market of injectable peptide-based substances being promoted online for weight loss.

Among 28,953 NAE reports associated with GLP-1 RAs, 19 distinct NAE signals were identified using reporting odds ratios (RORs), including dizziness, tremor, dysgeusia, lethargy, taste disorder, presyncope, parosmia, allodynia, and hypoglycemic unconsciousness, etc

The $63-billion GLP-1 agonist industry is forecast to triple in the coming decade, so it's no surprise that pharmaceuticals companies of all sizes are scrambling to get in on the action

14 Servings Per Box Stock up on this GLP-1-friendly, weight loss-focused shake with 14 convenient servings per box, giving you a ready-to-mix solution that makes it easy to stay on top of your diet while enjoying a rich chocolate flavor